InVivo Therapeutics Corporation Appoints Steven McAllister as Interim CFO
Published: Dec 16, 2013
InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Steven McAllister as Interim Chief Financial Officer, effective December 31, 2013. He replaces Gregory Perry, who, as previously announced, will leave December 30, 2013 to join another local biotechnology company as its Chief Financial and Business Officer.
Help employers find you! Check out all the jobs and post your resume.